Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement of our report dated March 31, 2022, which includes an explanatory paragraph relating to TransCode Therapeutics, Inc.’s ability to continue as a going concern, relating to the financial statements of TransCode Therapeutics, Inc. appearing in the entity’s Annual Report on Form 10-K for the year ended December 31, 2021.
/s/ WithumSmith+Brown, PC
East Brunswick, New Jersey
June 9, 2022